The Shh subgroup comprises approximately one-third of all cases of human MBs [11, 12]; moreover, to this group belongs the large majority of published MB animal models (e.g., the mice heterozygous for Patched1, a Shh receptor inhibiting the Shh pathway) [11, 13–16]. The gene discussed is SHH; the disease is Mobius syndrome.